A Telacebec-Shaped Puzzle Piece in the Treatment of Mycobacterial Diseases.
作者信息
de Jong Bouke C
机构信息
Mycobacteriology Unit Institute of Tropical Medicine Antwerp, Belgium.
出版信息
Am J Respir Crit Care Med. 2025 Aug;211(8):1341-1342. doi: 10.1164/rccm.202503-0598ED.
Abstract
摘要
相似文献
1
A Telacebec-Shaped Puzzle Piece in the Treatment of Mycobacterial Diseases.用于治疗分枝杆菌病的特拉塞贝克形状拼图块。
Am J Respir Crit Care Med. 2025 Aug;211(8):1341-1342. doi: 10.1164/rccm.202503-0598ED.
2
Telacebec, a Potent Agent in the Fight against Tuberculosis: Findings from a Randomized, Phase 2 Clinical Trial and Beyond.替拉塞贝克，一种抗结核的强效药物：一项随机2期临床试验及后续研究结果
Am J Respir Crit Care Med. 2025 Aug;211(8):1504-1512. doi: 10.1164/rccm.202408-1632OC.
3
Removal of Horizontally Impacted Mandibular Third Molars Using the Three-Piece or T-Shaped Tooth Sectioning Method.采用三段式或 T 形分牙法拔除水平阻生下颌第三磨牙。
J Oral Maxillofac Surg. 2024 Aug;82(8):968-975. doi: 10.1016/j.joms.2024.03.036. Epub 2024 Apr 5.
4
"It Was Like the Final Piece in the Puzzle for Me": A Qualitative Study on the Experiences of Autistic Women Initially Diagnosed with Borderline Personality Disorder.“对我来说，这就像拼图中的最后一块”：一项关于最初被诊断为边缘型人格障碍的自闭症女性经历的定性研究
Autism Adulthood. 2024 Dec 2;6(4):428-437. doi: 10.1089/aut.2023.0031. eCollection 2024 Dec.
5
Structure of mycobacterial CIIICIV respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203).分枝杆菌 CIIICIV 呼吸超级复合物与结核候选药物特拉塞韦（Q203）结合的结构。
Elife. 2021 Sep 30;10:e71959. doi: 10.7554/eLife.71959.
6
Two-piece versus single-piece patient-specific titanium subperiosteal implants in atrophied edentulous mandibles: A finite element analysis.萎缩性无牙下颌骨中两件式与一体式患者定制钛骨膜下植入物的有限元分析
Comput Biol Med. 2025 Sep;196(Pt C):110897. doi: 10.1016/j.compbiomed.2025.110897. Epub 2025 Aug 7.
7
FIRST RECORD OF A PARASITE, DACTYLOGYRUS CF. SKRJABINI (MONOGENOIDEA: DACTYLOGYRIDAE), INFECTING INVASIVE SILVER CARP, HYPOPHTHALMICHTHYS MOLITRIX (VALENCIENNES, 1844) (CYPRINIFORMES: XENOCYPRIDIDAE) IN NORTH AMERICA.首次记录寄生虫，Dactyloxyrus cf. Skrjabin（单殖目：Dactylogyridae），感染入侵性银鲤，Hypophthalmichthys molitrix（Valenciennes，1844）（鲤形目：鲤科）在北美的情况。
J Parasitol. 2023 May 1;109(3):233-243. doi: 10.1645/23-11.
8
The effectiveness of pressure support ventilation and T-piece in differing duration among weaning patients: A systematic review and network meta-analysis.压力支持通气与T型管在撤机患者不同时长应用中的有效性：一项系统评价与网状Meta分析
Nurs Crit Care. 2023 Jan;28(1):120-132. doi: 10.1111/nicc.12781. Epub 2022 Jun 1.
9
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece.压力支持通气或 T 型管自主呼吸试验。
N Engl J Med. 2022 Nov 17;387(20):1843-1854. doi: 10.1056/NEJMoa2209041. Epub 2022 Oct 26.
10
Mycobacterial infection and atopy in childhood: a systematic review.儿童期分枝杆菌感染与特应性：一项系统评价
Pediatr Allergy Immunol. 2007 Nov;18(7):551-9. doi: 10.1111/j.1399-3038.2007.00569.x.
本文引用的文献
1
Telacebec, a Potent Agent in the Fight against Tuberculosis: Findings from a Randomized, Phase 2 Clinical Trial and Beyond.替拉塞贝克，一种抗结核的强效药物：一项随机2期临床试验及后续研究结果
Am J Respir Crit Care Med. 2025 Aug;211(8):1504-1512. doi: 10.1164/rccm.202408-1632OC.
2
Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs.印度尼西亚在使用氨苯砜治疗麻风病方面面临的挑战——迫切需要获得替代抗菌药物。
Lancet Reg Health Southeast Asia. 2025 Feb 26;34:100555. doi: 10.1016/j.lansea.2025.100555. eCollection 2025 Mar.
3
Contribution of telacebec to novel drug regimens in a murine tuberculosis model.替拉塞贝在小鼠结核病模型中对新型药物方案的贡献。
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0096224. doi: 10.1128/aac.00962-24. Epub 2024 Dec 9.
4
Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: A cross-sectional study.氯法齐明诱导的皮肤色素沉着是麻风病治疗中耻辱感的一个来源：一项横断面研究。
Trop Med Int Health. 2024 Apr;29(4):327-333. doi: 10.1111/tmi.13977. Epub 2024 Feb 13.
5
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.简短口服方案治疗肺部利福平耐药结核病（TB-PRACTECAL）：一项开放标签、随机、对照、2B-3 期、多臂、多中心、非劣效性试验。
Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16.
6
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.贝达喹啉-普托马尼德-利奈唑胺方案治疗耐药结核病。
N Engl J Med. 2022 Sep 1;387(9):810-823. doi: 10.1056/NEJMoa2119430.
7
Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.双重抑制末端氧化酶可根除耐抗生素结核分枝杆菌。
EMBO Mol Med. 2021 Jan 11;13(1):e13207. doi: 10.15252/emmm.202013207. Epub 2020 Dec 7.
8
Telacebec (Q203), a New Antituberculosis Agent.替拉塞贝克（Q203），一种新型抗结核药物。
N Engl J Med. 2020 Mar 26;382(13):1280-1281. doi: 10.1056/NEJMc1913327.
Zotero 插件